Skip to main content
Equibles
IQV logo

IQV · Iqvia Holdings Inc.

Track IQV — free

Use IQV with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$267.77 -3.85 (-1.42%) At close · Sep 4
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$44.69B
Shares
166.90M

IQV metrics

91 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$267.77
Market cap
$44.69B

Price action

19 metrics
Price change (1W)
+2.3%
Price change (30D)
+10.7%
Price change (3M)
+46.0%
Price change (6M)
+53.5%
Price change (YTD)
+18.8%
Price change (1Y)
+45.5%
Trailing year
Price change (5Y)
+1.7%
52-week high
$271.62
52-week low
$156.66
Change from 52-week high
-1.4%
Change from 52-week low
+70.9%
Annualized volatility
41.3%
Beta
0.8
RSI (14D)
69.6
Price vs SMA 50
+16.4%
Price vs SMA 200
+32.6%
Avg volume (3M)
1.44M
Relative volume
0.8
Average dollar volume
$313.89M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
166.90M

Valuation

12 metrics
P / E (TTM)
33.3
Trailing earnings · reciprocal yield 3.0%
PEG ratio
2.2
EV / revenue
3.5×
reciprocal yield 28.5%
EV / EBITDA
17.4×
reciprocal yield 5.8%
EV / EBIT
26.6×
reciprocal yield 3.8%
P / sales
2.7×
reciprocal yield 37.2%
P / book
7.2
reciprocal yield 13.9%
FCF yield
4.7%
TTM · current market cap
Buyback yield
3.2%
P / FCF
21.1
reciprocal yield 4.7%
P / operating cash flow
16.5
reciprocal yield 6.1%
Earnings yield
3.1%

Historical valuation

8 metrics
P / E historical average (3Y)
28.0×
reciprocal yield 3.6%
P / E historical average (5Y)
35.5×
reciprocal yield 2.8%
EV / revenue historical average (3Y)
3.1×
reciprocal yield 32.1%
EV / revenue historical average (5Y)
3.4×
reciprocal yield 29.4%
EV / EBIT historical average (3Y)
23.3×
reciprocal yield 4.3%
EV / EBIT historical average (5Y)
28.3×
reciprocal yield 3.5%
EV / EBITDA historical average (3Y)
15.0×
reciprocal yield 6.7%
EV / EBITDA historical average (5Y)
16.8×
reciprocal yield 5.9%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-28

Profitability

9 metrics
Gross margin
—
Operating margin
13.2%
Trailing 12 months
Net margin
8.3%
Gross profit (TTM)
—
Operating profit (TTM)
$2.20B
Net income (TTM)
$1.39B
Trailing 12 months
Diluted EPS (TTM)
$8.05
FCF margin
12.7%
Effective tax rate
15.7%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-11.74

Growth

11 metrics
Revenue growth YoY
+8.4%
Year over year
Net income growth YoY
+10.0%
Revenue (TTM)
$16.63B
Trailing 12 months
EPS growth YoY
+15.0%
Shares change YoY
-4.3%
Year over year · fewer shares
Revenue CAGR (3Y)
+4.2%
Revenue CAGR (5Y)
+7.5%
EPS CAGR (3Y)
+11.1%
EPS CAGR (5Y)
+40.5%
FCF CAGR (3Y)
+8.9%
FCF CAGR (5Y)
+8.8%

Quality

14 metrics
Return on equity
22.3%
Return on assets
4.7%
Debt / equity
2.5
Current ratio
0.7
EBITDA (TTM)
$3.37B
Free cash flow (TTM)
$2.12B
Quick ratio
0.7
Interest coverage
2.9
Net debt / EBITDA
4.1
Return on invested capital
9.3%
Trailing 12 months
Net cash
−$13.73B
Latest balance sheet
Cash & equivalents
$1.95B
Total assets
$29.68B
Total debt
$15.83B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$2.70B
Capital expenditures (TTM)
$588.00M
R&D (TTM)
—
SG&A (TTM)
$1.99B
Stock compensation (TTM)
$240.00M
R&D / revenue
—
Stock compensation / revenue
1.4%

Ownership (13F)

3 metrics
13F filers
1,088
13F filer change QoQ
+8
Institutional ownership
94.3%

Short interest

3 metrics
Short interest
2.5%
Latest settlement · 3.6 days to cover
Days to cover
3.6d
Short-squeeze score
58 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$29.89M
Insider-sentiment score
11 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1478242 CUSIP 46266C105 13F (30d) 538 filings 516 filers Visit website Investor relations